Navigation Links
McMaster vaccine has pet owners feline groovy
Date:3/31/2011

Hamilton, ON (March 31, 2011) - Good-bye itching, watering eyes and sneezing. McMaster University researchers have developed a vaccine which successfully treats people with an allergy to cats.

Traditionally, frequent allergy shots have been considered the most effective way to bring relief other than getting rid of the family pet -- for the eight to 10% of the population allergic to cats.

Both options one difficult and costly, the other troubling - may now be tossed aside thanks to the work of immunologist Mark Larch, professor in the Department of Medicine in the Michael G. DeGroote School of Medicine and Canada Research Chair in Allergy & Immune Tolerance.

Building on research he's conducted for the past 10 years in Canada and Britain, Larch and his research team have developed a vaccine which is effective and safe with almost no side effects. The research is published in a recent (January 2011) issue of the Journal of Allergy & Clinical Immunology, a leading journal in the allergy field.

The researchers took one protein (molecule) that cats secrete on their fur which causes the majority of allergic problems. Using blood samples from 100 patient volunteers allergic to cats, they deconstructed the molecule and identified short regions within the protein which activate T-cells (helper cells that fight infection) in the immune system.

Using the amino acid code for the whole protein, researchers made synthetic versions of these regions. For the cat allergy vaccine, they found seven peptides (strings of amino acids). "And those synthetic peptides are what we mix together to make the vaccine," said Larch. "We picked the peptides that would work in as much of the population as possible."

Known as "peptide immunotherapy", a low dose of the vaccine is given into the skin. Initially, four to eight doses a year may be required, but the side effects of the traditional allergy shots do not arise, Larch said. The optimal dose will be determined in phase three clinical trials which are getting underway with a much larger group of cat allergy sufferers.

The development of a vaccine to treat people allergic to cats is the first in a line of vaccines developed with Adiga Life Sciences, a company established at McMaster in 2008. It is a joint venture between McMaster University and Circassia Ltd., a UK-based biotech company.

Adiga and McMaster are now collaborating on research into the use of peptide immunotherapy for house dust mite, ragweed, grass, birch tree and moulds.


'/>"/>

Contact: Veronica McGuire
vmcguir@mcmaster.ca
90-552-591-402-2169
McMaster University
Source:Eurekalert

Related medicine news :

1. Youth with IBD are less fit than their peers: McMaster study
2. McMaster study contradicts reports of problems with blood-thinner
3. McMaster researcher leads development of promising drug for inflammation
4. Scientists find candidate for new TB vaccine
5. New vaccine candidate shows strong potential to prevent highly contagious norovirus
6. Research may lead to new and improved vaccines
7. Sones Innovation Award honors breast cancer vaccine research
8. Using a molecular switch to turn on cancer vaccines
9. An Alzheimers vaccine in a nasal spray
10. Experts explore vaccines: Science, legal, social issues at New York Academy of Sciences
11. New vaccine technology protects mice from hepatitis C virus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... ... May 24, 2016 , ... In light of recent heavy flooding in ... of contaminated well water throughout the Houston area. , Heavy floodwaters have led to ... exposed to contaminants. Residents may not even be aware of the contamination of their ...
(Date:5/24/2016)... ... ... The Dream Builders Project, a 501(c)3 nonprofit organization based in Los Angeles, ... Mexico on Saturday, May 21st. The volunteers took the children out for the day ... 15 volunteers traveled from Los Angeles to Tijuana, Mexico for the day in the ...
(Date:5/24/2016)... (PRWEB) , ... May 24, 2016 , ... ... and tick-borne disease research and education, today announced that it has named Scott ... of the Bonnie J. Addario Lung Cancer Foundation (ALCF) in San Francisco, where ...
(Date:5/24/2016)... ... May 24, 2016 , ... PhysicianOne Urgent Care, advocators in helping ... bites and how to avoid being bitten this spring. , The official tick ... Ticks, small spider-like insects, are known for attaching themselves to their prey while they ...
(Date:5/24/2016)... ... May 24, 2016 , ... Applications ... multiplex immunoassays are widely used for cell and protein analysis. Keeping updated on ... quality and efficiency in these areas. , LabRoots introduces a new complementary ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... 24, 2016 ARANZ Medical  Ltd ... healthcare sector, has been named the Coretex Hi-Tech Emerging Company ... Dr Bruce Davey , CEO of ARANZ ...  It,s really good to be recognised for the work we ... are used in 35 countries around the world from Sub-Saharan ...
(Date:5/24/2016)... , May 24, 2016 ... doble terapia del mundo, introduce catéteres para la ... OrbusNeich, una compañía global especializada en el ... ha expandido su cartera incluyendo productos para tratar ... y Scoreflex™ PTA son los dispositivos de primera ...
(Date:5/23/2016)... According to a new ... Product (Wheelchair, Scooters, Medical Beds, Bathroom Safety, Mechanical, ... Wound), Accessories (Lifting, Transfer) & by End User ... MarketsandMarkets, the patient handling equipment market is expected ... a CAGR of 10.5% during the forecast period ...
Breaking Medicine Technology: